· Largest real-world, blinded, multi-site validation of AI molecular profiling from routine diagnostic images · Software identifies clinically actionable cancer biomarkers in minutes rathe
Cambridge, UK, 3 November 2025 – Panakeia (“the Company”), a pioneer in AI-enabled multi-omic biomarker profiling, is pleased to confirm that various team members will be attending and presenting at